SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-23-000090
Filing Date
2023-11-07
Accepted
2023-11-07 16:18:57
Documents
59
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20230930.htm   iXBRL 10-Q 1041456
2 EX-31.1 a2023-q310xqex311.htm EX-31.1 10758
3 EX-31.2 a2023-q310xqex312.htm EX-31.2 10856
4 EX-32.1 a2023-q310xqex321.htm EX-32.1 4950
5 EX-32.2 a2023-q310xqex322.htm EX-32.2 4980
11 PIPELINE abus-20230930_g1.jpg GRAPHIC 61895
  Complete submission text file 0001447028-23-000090.txt   5277603

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20230930.xsd EX-101.SCH 39960
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20230930_cal.xml EX-101.CAL 45827
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20230930_def.xml EX-101.DEF 176268
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20230930_lab.xml EX-101.LAB 444467
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20230930_pre.xml EX-101.PRE 288084
53 EXTRACTED XBRL INSTANCE DOCUMENT abus-20230930_htm.xml XML 693265
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 231384218
SIC: 2834 Pharmaceutical Preparations